mRNA Vaccines and Therapeutics Market Research Report 2022, Size, Share, Trends and Forecast to 2027

According to the latest report by IMARC Group, titled "mRNA Vaccines and Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global mRNA vaccines and therapeutics market size reached US$ 54.37 Billion in 2021.

Messenger Ribonucleic Acid (mRNA) is a single-stranded RNA molecule that plays a vital role in human biology, especially in protein synthesis. Numerous mRNA vaccines and therapeutics are now available in the market that are administered in the human body to trigger virus-detecting immune sensors. This is executed to induce the production of antibodies that further bind to the potential pathogens. These solutions use genetic information to produce viral antigen proteins within the cells and provide acquired immunity through an RNA containing vector, such as lipid nanoparticles. Their use aids in boosting the immunity of the body by improving B- and T-cell responses.

Request Free Sample Report: https://www.imarcgroup.com/mrna-vaccines-therapeutics-market/requestsample

Market Trends

mRNA vaccines represent a promising alternative to conventional vaccines due to their high potency, capacity for rapid development and potential for low-cost manufacture. Along with this, there has been a rise in the requirement of vaccines and therapeutics for the treatment of various viral infections, such as Ebola and Human Immunodeficiency Virus (HIV). Since these therapeutics are considered to be more effective against pathogens due to their enhanced immunogenicity, numerous private and public companies are heavily investing in extensive research and development (R&D) activities in the field of biotechnology for vaccine development and protein replacement therapy using mRNA. Additionally, on account of the outbreak of the coronavirus disease (COVID-19) pandemic, numerous companies are currently engaging in the development of a vaccine to curb the transmission of the virus, thereby creating a positive outlook for the market. Moderna, Inc. is one such leading mRNA technology firm that is actively invested in the development of the mRNA-1273 vaccine against the novel coronavirus (SARS-CoV-2). It has registered positive interim results in its Phase 1 study and has already proceeded with the Phase 3 study of mRNA-1273 that is being conducted in collaboration with the NIH and BARDA. The market is further driven by the significant improvements in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 40.55 Billion by 2027.

Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/mrna-vaccines-therapeutics-market

List of Key Companies Covered in this Market Report:

Argos Therapeutics Inc. (SCM Life Science and Genexine)
AstraZeneca (NYSE: AZN)
Bayer AG (OTCMKTS: BAYRY)
BioNTech AG (NASDAQ: BNTX)
Boehringer Ingelheim
CRISPR Therapeutics (NASDAQ: CRSP)
CureVac AG
eTheRNA Immunotherapies
Ethris GmbH
In-Cell-Art
Intellia Therapeutics Inc. (NASDAQ: NTLA)
Moderna Therapeutics (NASDAQ: MRNA)
Sangamo Therapeutics (NASDAQ: SGMO)
Tiba Biotech LLC
Translate Bio Inc. (NASDAQ: TBIO)

The report has segmented the market on the basis of vaccine type, treatment type, vaccine manufacturing, application, end-user and geography.

Breakup by Vaccine Type:

Self-amplifying mRNA-based Vaccines
Conventional Non-Amplifying mRNA-Based Vaccines
Others

Breakup by Treatment Type:

Bioengineered Vaccine Based Treatment
Gene Therapy (Gene Silencing/Suppression)
Gene Transcription (Protein Generation)
Cell Therapy
Monoclonal Antibody Based Treatment
Others

Breakup by Vaccine Manufacturing:

In-House mRNA Vaccine Manufacturing
Out-Sourced mRNA Vaccine Manufacturing

Breakup by Application:

Cancer
Infectious Disease
Vaccines In-vivo Therapeutics
Gene Editing
Others

Breakup by End-User:

Hospitals and Clinics
Research Organizations
Others

Breakup by Geography:

North America (U.S. & Canada)
Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
Latin America (Brazil, Mexico)
Middle East & Africa

Key highlights of the report:

Market Performance (2016-2021)
Market Outlook (2022- 2027)
Porter's Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Related Report by IMARC Group:

Remote Patient Monitoring Market Report: https://www.imarcgroup.com/remote-patient-monitorning-market

Steam Autoclaves Market Report: https://www.imarcgroup.com/steam-autoclaves-market

Hospital Information System Market Report: https://www.imarcgroup.com/hospital-information-system-market

Capnography Devices Market Report: https://www.imarcgroup.com/capnography-devices-market

Intracranial Pressure Monitoring Market Report: https://www.imarcgroup.com/intracranial-pressure-monitoring-market

Vital Signs Monitoring Devices Market Report: https://www.imarcgroup.com/vital-signs-monitoring-devices-market

Positron Emission Tomography Market Report: https://www.imarcgroup.com/positron-emission-tomography-market

Contact US

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.